BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38852963)

  • 1. Does the Left Heart Know What the Right Heart Is Doing in Patients With Systemic Sclerosis and Pulmonary Hypertension?
    Lammi MR; Agrawal V; Mathai SC
    Chest; 2024 Jun; 165(6):1288-1290. PubMed ID: 38852963
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pulmonary hypertension, the "bĂȘte noire" of systemic diseases: from systemic sclerosis to hereditary hemorrhagic telangiectasia].
    Launay D
    Rev Med Interne; 2006 Nov; 27(11):899-902. PubMed ID: 17133666
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary vascular aspects of systemic sclerosis.
    Wallman LL; Penny R; Williamson DJ
    Aust N Z J Med; 1996 Apr; 26(2):150-3. PubMed ID: 8744610
    [No Abstract]   [Full Text] [Related]  

  • 4. Is exercise-induced pulmonary hypertension ready for prime time in systemic sclerosis?
    Steen VD; Champion H
    Int J Clin Pract Suppl; 2011 Jan; (169):1-3. PubMed ID: 21176008
    [No Abstract]   [Full Text] [Related]  

  • 5. Pulmonary arterial hypertension in systemic sclerosis: can we predict responders for successful therapy?
    Sasahara AA
    J Rheumatol; 2009 Apr; 36(4):665-6. PubMed ID: 19342719
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary arterial hypertension: are we doing enough to identify systemic sclerosis patients at high risk of this rare condition?
    Black C
    Rheumatology (Oxford); 2005 Feb; 44(2):141-2. PubMed ID: 15681336
    [No Abstract]   [Full Text] [Related]  

  • 7. Right ventricular function in systemic sclerosis-associated pulmonary arterial hypertension.
    Koestenberger M; Ravekes W
    J Rheumatol; 2013 Jan; 40(1):90. PubMed ID: 23280165
    [No Abstract]   [Full Text] [Related]  

  • 8. P-wave amplitude and pulmonary artery pressure in scleroderma.
    Wokhlu N; Hsu VM; Wilson A; Moreyra AE; Shindler D
    J Electrocardiol; 2006 Oct; 39(4):385-8. PubMed ID: 16919671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors relating to impaired stroke volume during the 6-minute walk test in patients with systemic sclerosis.
    Someya F; Mugii N; Oohata S
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):152-156. PubMed ID: 27463117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dropped head syndrome and Systemic sclerosis.
    Rosato E; Rossi C; Salsano F
    Joint Bone Spine; 2009 May; 76(3):301-3. PubMed ID: 19321373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary hypertension in systemic sclerosis: bete noire no more?
    Varga J
    Curr Opin Rheumatol; 2002 Nov; 14(6):666-70. PubMed ID: 12410089
    [No Abstract]   [Full Text] [Related]  

  • 12. Pulmonary Circulation on the Crossroads Between the Left and Right Heart in Systemic Sclerosis: A Clinical Challenge for Cardiologists and Rheumatologists.
    Gargani L; Voilliot D; D'Alto M; Agoston G; Moreo A; Serra W; Pieri F; Mori F; Wierzbowska-Drabik K; Matucci-Cerinic M; Moggi-Pignone A
    Heart Fail Clin; 2018 Jul; 14(3):271-281. PubMed ID: 29966626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension in systemic sclerosis: different phenotypes.
    Launay D; Sobanski V; Hachulla E; Humbert M
    Eur Respir Rev; 2017 Sep; 26(145):. PubMed ID: 28954767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary hypertension: a correct diagnosis for a suitable therapy in scleroderma patients.
    Giordano N; Montella A; Corallo C; Ruocco G; Chirico C; Palazzuoli A; Nuti R; Pecetti G
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S182-9. PubMed ID: 26339897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echocardiographic Predictors for Worsening of Six-Minute Walk Distances in Patients With Systemic Sclerosis (Scleroderma).
    Kusunose K; Yamada H; Nishio S; Hirata Y; Seno H; Saijo Y; Ise T; Tobiume T; Yamaguchi K; Yagi S; Soeki T; Wakatsuki T; Sata M
    Am J Cardiol; 2017 Jul; 120(2):315-321. PubMed ID: 28532772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nailfold capillary abnormality and pulmonary hypertension in systemic sclerosis.
    Ohtsuka T; Hasegawa A; Nakano A; Yamakage A; Yamaguchi M; Miyachi Y
    Int J Dermatol; 1997 Feb; 36(2):116-22. PubMed ID: 9109008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment and management of scleroderma lung disease.
    Bolster MB; Silver RM
    Curr Opin Rheumatol; 1999 Nov; 11(6):508-13. PubMed ID: 10551676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinico-functional characteristics of pulmonary arterial hypertension in systemic scleroderma].
    Mirrakhimov MM; Moldotashev IK; Bakeeva ME; Shmidt GF
    Ter Arkh; 1994; 66(3):67-71. PubMed ID: 8202858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic sclerosis - a systematic overview: part 1 - disease characteristics and classification, pathophysiologic concepts, and recommendations for diagnosis and surveillance.
    Klein-Weigel P; Opitz C; Riemekasten G
    Vasa; 2011 Jan; 40(1):6-19. PubMed ID: 21283969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension complicating systemic sclerosis: A successful pregnancy outcome.
    Kah Teik C; Ahmad MF; Soon Leong Y; Mohamed Ismail NA
    J Obstet Gynaecol; 2017 Jul; 37(5):677-678. PubMed ID: 28350528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.